Key result
In patients with acute decompensated pulmonary hypertension, the use of renal replacement therapy in the ICU was associated with significantly higher 90-day mortality compared to no RRT (83.3% vs. 42.6%, p=0.01).
Why the study?
Predictors and timing for renal replacement therapy in acute decompensated pulmonary hypertension are unknown, and mortality among patients requiring this therapy is high.
Is the use of renal replacement therapy associated with increased mortality in patients with acute decompensated pulmonary hypertension admitted to the ICU?
Cohort (n=73)
Yes
Is the use of renal replacement therapy associated with increased mortality in patients with acute decompensated pulmonary hypertension admitted to the ICU?
Absolute Event Rate: 83.3% vs 42.6%
p-value: p=0.01
In patients with acute decompensated pulmonary hypertension requiring ICU admission, the need for renal replacement therapy can be predicted by admission creatinine and right atrial pressure, and is associated with exceedingly high in-hospital and 90-day mortality.
RRT need in acute decompensated PH signals high mortality; hypothesis-generating for risk stratification, requiring prospective validation before practice change.
BACKGROUND: Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (PH) are characterized hemodynamically by pre-capillary PH. Acute worsening of systemic congestion and/or reduced right ventricular flow output in patients with pre-capillary PH characterizes an episode of acute decompensated PH. Acute kidney injury (AKI) is a common complication in this population and those patients frequently use renal replacement therapy (RRT). Predictors and timing for RRT in acute decompensated PH are unknown and mortality of patients who require this therapy is high. We hypothesize that AKI and hypervolemia are associated with use of RRT during episodes of acute decompensated PH in patients with pre-capillary PH requiring intensive care unit (ICU) admission. AIM: Explore variables associated with RRT use, develop a decision tree model to predict use of RRT in acute decompensated PH and analyze ICU, in-hospital and 90-days mortality in this population. MATERIALS AND METHODS: Multicenter retrospective cohort study including patients with pulmonary arterial hypertension and chronic thromboembolic PH with unplanned admission in the ICU for acute decompensated PH. Acute decompensated PH was defined by acute right ventricular failure leading to low cardiac output and elevated right ventricle filling pressures. We employed two multivariable logistic regression models using directed acyclic graphs to identify confounders. Unadjusted and adjusted odds ratios and 95% confidence intervals were used to measure the association between variables and RRT use. RESULTS: Some 73 patients were included, 16.4% (n=12) of patients required RRT during ICU stay. In the univariate analysis, right atrial pressure (RAP) on last right heart catheterization, and creatinine upon ICU admission were associated with use of RRT and were included in the multivariable model and in the decision tree model. The decision tree model based on RAP and creatinine showed sensitivity of 58.3% and specificity of 100% with area under the receiver operating characteristic curve of 0.81 for predicting RRT use in the ICU. In-hospital mortality and 90-days mortality of patients who used RRT were higher than in patients that did not use RRT (75.0% vs. 34.4%, p < 0.01 and 83.3% vs. 42.6%, p = 0.01, respectively). CONCLUSION: The decision tree model based on creatinine upon admission and RAP, which is a surrogate of hypervolemia, can identify patients at risk for RRT. Increased ICU, in-hospital, and 90-days mortality were observed in patients with acute decompensated PH who used RRT in the ICU.
No takes yet. Share an insight, caveat, or question.
Garcia et al. (2022) conducted a cohort in Acute decompensated pulmonary hypertension (n=73). Renal replacement therapy (RRT) vs. No renal replacement therapy was evaluated on 90-day mortality (p=0.01). In patients with acute decompensated pulmonary hypertension, the use of renal replacement therapy in the ICU was associated with significantly higher 90-day mortality compared to no RRT (83.3% vs. 42.6%, p=0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: